Eventide Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-535,000	Closed	-$29.5M	–	169
2020 Q3	$29.5M	Hold	535,000	–	–	0.58%	58
2020 Q2	$33.8M	Hold	535,000	–	–	0.73%	48
2020 Q1	$27.3M	Hold	535,000	–	–	0.89%	42
2019 Q4	$42.5M	Hold	535,000	–	–	1.2%	35
2019 Q3	$26M	Hold	535,000	–	–	0.86%	44
2019 Q2	$28.1M	Buy	535,000 +168,000	+46%	+$8.84M	0.86%	41
2019 Q1	$19.4M	Hold	367,000	–	–	0.67%	58
2018 Q4	$15.1M	Buy	367,000 +137,000	+60%	+$5.62M	0.67%	52
2018 Q3	$8.74M	Buy	+230,000	New	+$8.74M	0.32%	81
2017 Q4	–	Sell	-190,000	Closed	-$5.9M	–	145
2017 Q3	$5.9M	Hold	190,000	–	–	0.33%	73
2017 Q2	$5.2M	Buy	190,000 +25,000	+15%	+$684K	0.32%	70
2017 Q1	$6.08M	Hold	165,000	–	–	0.4%	65
2016 Q4	$2.38M	Hold	165,000	–	–	0.16%	94
2016 Q3	$3.8M	Hold	165,000	–	–	0.23%	76
2016 Q2	$2.74M	Hold	165,000	–	–	0.17%	89
2016 Q1	$2.62M	Hold	165,000	–	–	0.15%	97
2015 Q4	$5.33M	Buy	165,000 +149,521	+966%	+$4.83M	0.27%	86
2015 Q3	$653K	Buy	+15,479	New	+$653K	0.04%	108